Gogolook Co., Ltd. logo

Gogolook Co., Ltd. (6902)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
128. 00
+0.5
+0.3922%
NT$
4.4B Market Cap
- P/E Ratio
- Div Yield
101,689 Volume
- Eps
NT$ 127.5
Previous Close
Add Transaction
Day Range
126 132
Year Range
65.8 153
Want to track 6902 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6902 closed today higher at NT$128, an increase of 0.3922% from yesterday's close, completing a monthly decrease of -1.1583% or -NT$1.5. Over the past 12 months, 6902 stock gained 66.884%.
6902 is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, missed the consensus estimates by -1.07%. On average, the company has fell short of earnings expectations by -0.2267%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

6902 Chart

People also search for

Favite Inc.
NT$ 89
-1.3304%
BenQ Materials Corp.
NT$ 24.8
-2.9354%
Kaimei Electronic Corp.
NT$ 128.5
+3.629%
PLANET Technology Corporation
NT$ 159.5
-0.9317%
Aces Electronic Co., Ltd.
NT$ 111
+1.8349%

Gogolook Co., Ltd. (6902) FAQ

What is the stock price today?

The current price is NT$128.00.

On which exchange is it traded?

Gogolook Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 6902.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.4B.

Has Gogolook Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Gogolook Co., Ltd. Profile

Software Industry
Information Technology Sector
Mr. Jackie Cheng CEO
TWSE Exchange
TW0006902000 ISIN
TW Country
286 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bonraybio Co., Ltd. is a company in the development stage, primarily focused on creating medical instruments and solutions specifically tailored for the male infertility market. Founded in 2015 and headquartered in Taichung, Taiwan, Bonraybio has dedicated itself to addressing the challenges in male reproductive health by developing advanced technologies designed to improve diagnosis and analysis in the field of andrology.

Products and Services

Bonraybio Co., Ltd. offers a comprehensive range of products and services designed to facilitate advanced semen analysis and improve the diagnostic processes associated with male infertility. These include:

  • LensHooke X12 PRO Semen Analysis Systems: These systems are designed for in-depth semen analysis, providing detailed information that can help assess male fertility levels.
  • LensHooke X1 PRO Semen Quality Analyzers: These analyzers are tailored for quick and accurate assessments of semen quality, making them critical tools in male infertility diagnostics.
  • CS3 Semen Test Slides: Specifically designed for use with Bonraybio's analysis systems, these slides are essential consumables for conducting semen tests.
  • CA0/CA1 Sperm Separation Solutions: These solutions are formulated to enhance the separation of sperm, facilitating improved analysis and potential fertility treatments.
  • CS1 Semen Test Cassettes: Used in conjunction with the company’s semen analyzers, these cassettes play a vital role in the standardized collection and analysis of semen samples.
  • X QC Reticles, X QC Video Tools, and X QC Beads: These quality control tools ensure the accuracy and reliability of the semen analysis conducted using Bonraybio's systems.
  • Sperm DNA Fragmentation Test Kits: These kits are used for assessing the integrity of sperm DNA, providing important insights into potential fertility issues.
  • S10 Data Consolidation Software: This software integrates and consolidates data from multiple sources, streamlining the analysis and reporting process in semen analysis protocols.

Contact Information

Address: No. 102 Roosevelt Road, Taipei, Taiwan, 106033
Phone: 886 2 2365 8099